Skip to main content
Home
Business Development
Products
Contact
A
-
A
A
+
Print
GLOBAL PRESENCE
Africa
Morocco
Nigeria
South Africa
Asia Pacific
Australia
Japan
Malaysia
Myanmar
Sri Lanka
Europe
France
Germany
Ireland
Italy
Lithuania
The Netherlands
Poland
Romania
Spain
United Kingdom
Denmark
Finland
Hungary
Norway
Sweden
Switzerland
North America
Canada
USA
South America
Brazil
CIS
Russia
Ukraine
Affiliated Websites
Taro Pharmaceutical Industries Limited
Dusa Pharmaceuticals
About Us
Milestones
Vision & Values
Board of Directors
Acquisitions & Joint Ventures
Awards & Accreditations
Operations
Research & Development
Manufacturing
Quality
Responsibility
CSR
EHS
HIV/AIDS
Investors
Financials
Annual Reports & Presentations
ANNUAL REPORT OF SUBSIDIARY COMPANIES
Shareholder's Information
Archives
Media
Press Releases
Media Kit
Careers
Work with us
Life @ Sun Pharma
HOME
ABOUT
Milestones
Board of Directors
Acquisitions & Joint Ventures
Awards & Accreditations
OPERATIONS
Research & Development
Manufacturing
Quality
PRODUCTS
Formulations
Active Pharmaceutical Ingredients
OTC
RESPONSIBILITY
CSR
Ranbaxy Community Healthcare Society
Ranbaxy - Daiichi Sankyo Joint Initiative
Ranbaxy Science Foundation
EHS
HIV/AIDS
Anti-Malaria
INVESTORS
Financials
Annual Reports & Presentation
Shareholder's Information
Stock Information
Dividend history
Unclaimed Dividend
Statutory Communications
Our Policies And Codes
Tools
Investors FAQs
Archives
Sun Pharma - Ranbaxy Merger
Ranbaxy Archives
Quarterly Results
Annual Reports
Corporate Governance
Presentations
Share Holding Pattern
Unclaimed Dividend
MEDIA
Press Releases
In the News
Media Kit
CAREERS
Work with us
Life @ Sun Pharma
Academic Programmes
BUSINESS DEVELOPMENT
CONTACT
GLOBAL PRESENCE
AFRICA
Morocco
Nigeria
South Africa
ASIA PACIFIC
Australia
Malaysia
Myanmar
Sri Lanka
EUROPE
France
Germany
Ireland
Italy
Lithuania
The Netherlands
Poland
Romania
Spain
United Kingdom
Denmark
Finland
Norway
NORTH AMERICA
Canada
USA
SOUTH AMERICA
Brazil
CIS
Russia
Ukraine
AFFILIATED WEBSITES
Taro Pharmaceutical Industries Limited
Dusa Pharmaceuticals
Text Size
A
A
A
Annual Report for Insite vision
Tell a Friend
Print
Home
»
Investors
»
Archives
» Annual Report for Insite vision
Financials
Annual Reports & Presentations
ANNUAL REPORT OF SUBSIDIARY COMPANIES
Shareholder's Information
Stock Information
Dividend history
Unclaimed Dividend
Statutory Communications
Our Policies And Codes
Tools
Details of Shares to IEPF
Credit Rating
Memorandum and Articles of Association
SPLL
Investors Contact
Archives
Sun Pharma - Ranbaxy Merger
Ranbaxy Archives
InSite Vision Archives
Annual Report 2014
2014 Annual Report and Form 10K
2014 Proxy Statement
Annual Report 2013
2013 Annual Report
Annual Report 2012
2012 Annual Report
Annual Report 2011
2011 Annual Report
Annual Report 2010
2010 Annual Report
Annual Report 2009
2009 Annual Report
2009 Form 10k A
Annual Report 2008
2008 Annual Report and Form 10K
2008 Form 10k A
Annual Report 2007
2007 Annual Report
2007 Form 10k
2007 Form 10k A
Annual Report 2006
2006 Annual Report
2006 Form 10k
2006 Form 10k A
CHOOSE YOUR REGION
Go to our
USA Site
View
Asia (Excluding India)
View
Go to our Europe Site
View
India
View
Middle East & Africa
View
CHOOSE YOUR COUNTRY
Australia
Denmark
Finland
France
Germany
Italy
Netherlands
Norway
Spain
Sweden
UK
USA